{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:41:58Z","timestamp":1760812918543,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.trim.2023.101855","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:13Z","timestamp":1684281613000},"page":"101855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience"],"prefix":"10.1016","volume":"79","author":[{"given":"Merve Gozde","family":"Sezgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicran","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2023.101855_bb0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41409-019-0583-4","article-title":"Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the lymphoma working party-European society for blood and marrow transplantation","volume":"55","author":"Dietrich","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2023.101855_bb0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41409-018-0372-5","article-title":"The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies","volume":"54","author":"Norman","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2023.101855_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","article-title":"A review of autologous stem cell transplantation in lymphoma","volume":"12","author":"Zahid","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"author":"Global Cancer Observatory (GLOBACAN)","key":"10.1016\/j.trim.2023.101855_bb0020"},{"author":"Center for International Blood and Marrow Transplant Research (CIBMTR)","key":"10.1016\/j.trim.2023.101855_bb0025"},{"author":"Center for International Blood and Marrow Transplant Research (CIBMTR)","key":"10.1016\/j.trim.2023.101855_bb0030"},{"issue":"22","key":"10.1016\/j.trim.2023.101855_bb0035","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","article-title":"Allogeneic stem cell transplantation: a historical and scientific overview","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.trim.2023.101855_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/CCO.0000000000000473","article-title":"The role of allogeneic stem cell transplantation in T-cell lymphoma","volume":"30","author":"Friedrichs","year":"2018","journal-title":"Curr. Opin. Oncol."},{"issue":"854","key":"10.1016\/j.trim.2023.101855_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0038-0814(21)00098-0","article-title":"Nursing care and allogeneic hematopoietic stem cell transplantation","volume":"66","author":"Guichard","year":"2021","journal-title":"Soins"},{"issue":"3","key":"10.1016\/j.trim.2023.101855_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12185-019-02594-1","article-title":"Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature","volume":"109","author":"Gaut","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.trim.2023.101855_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.beha.2017.10.009","article-title":"The role of stem cell transplantation in follicular lymphoma","volume":"31","author":"Hess","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"7","key":"10.1016\/j.trim.2023.101855_bb0060","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41409-020-01198-2","article-title":"Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial","volume":"56","author":"Tessoulin","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101855_bb0065","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.trim.2023.101855_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ejh.13691","article-title":"Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation","volume":"107","author":"Metzner","year":"2021","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.trim.2023.101855_bb0075","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1097\/NCC.0000000000000685","article-title":"The meaning of self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplantation","volume":"43","author":"White","year":"2020","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.trim.2023.101855_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2021.101997","article-title":"Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - a longitudinal observational study","volume":"53","author":"Stamm","year":"2021","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"7","key":"10.1016\/j.trim.2023.101855_bb0085","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/10428194.2020.1732959","article-title":"Relapse or refractory Hodgkin lymphoma: determining risk of relapse or progression after autologous stem-cell transplantation","volume":"61","author":"Bentolila","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2023.101855_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejon.2019.07.006","article-title":"Self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplant: a pilot study","volume":"42","author":"White","year":"2019","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"4","key":"10.1016\/j.trim.2023.101855_bb0095","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/bjh.17939","article-title":"Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the lymphoma working party-EBMT","volume":"196","author":"Guti\u00e9rrez-Garc\u00eda","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"9980","key":"10.1016\/j.trim.2023.101855_bb0100","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)60165-9","article-title":"Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin\u2019s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"385","author":"Moskowitz","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2023.101855_bb0105","first-page":"S2152","article-title":"Impact of frailty on hospital outcomes among patients with lymphoid malignancies receiving autologous hematopoietic stem cell transplantation in the United States","volume":"24","author":"Rubens","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.trim.2023.101855_bb0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4274\/tjh.galenos.2021.2020.0438","article-title":"Allogeneic hematopoietic stem cell transplantation in extranodal natural killer\/t-cell lymphoma","volume":"38","author":"Peng","year":"2021","journal-title":"Turk. J. Haematol."},{"issue":"1","key":"10.1016\/j.trim.2023.101855_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13045-020-00892-4","article-title":"Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Soci\u00e9t\u00e9 francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC)","volume":"13","author":"Mamez","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.trim.2023.101855_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbmt.2018.09.009","article-title":"Outcomes of patients with recurrent and refractory lymphoma undergoing allogeneic hematopoietic cell transplantation with BEAM conditioning and Sirolimus- and tacrolimus-based GVHD prophylaxis","volume":"25","author":"Salhotra","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.trim.2023.101855_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbmt.2015.09.014","article-title":"The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review","volume":"22","author":"Chaudhry","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.trim.2023.101855_bb0130","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1186\/s12885-018-5054-6","article-title":"Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis","volume":"18","author":"Owattanapanich","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.trim.2023.101855_bb0135","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/16078454.2021.2003071","article-title":"Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation","volume":"26","author":"Wang","year":"2021","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.trim.2023.101855_bb0140","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/10428194.2020.1742901","article-title":"Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients","volume":"61","author":"Rodr\u00edguez-Lobato","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.trim.2023.101855_bb0145","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1634\/theoncologist.2017-0499","article-title":"Autologous stem cell transplantation in elderly lymphoma patients in their 70s: outcomes and analysis","volume":"23","author":"Sun","year":"2018","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.trim.2023.101855_bb0150","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.21873\/invivo.12197","article-title":"New-onset post-transplant diabetes and therapy in long-term survivors after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Dalla Via","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.trim.2023.101855_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijnurstu.2017.01.004","article-title":"A nurse facilitated mind-body interactive exercise (Chan-Chuang qigong) improves the health status of non-hodgkin lymphoma patients receiving chemotherapy: randomised controlled trial","volume":"69","author":"Chuang","year":"2017","journal-title":"Int. J. Nurs. Stud."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:02:56Z","timestamp":1760810576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"alternative-id":["S0966327423000722"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101855","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101855"}}